Should immune checkpoint inhibitors be contraindicated in lung cancer patients with latent tuberculosis?

被引：1
|
作者：
Haddad, Fady G. H. [1 ]
Kattan, Clarisse [1 ]
Kattan, Joseph [1 ]
机构：
[1] St Joseph Univ, Hotel Dieu France Univ Hosp, Dept Hematol Oncol, Fac Med, Beirut, Lebanon
来源：
IMMUNOTHERAPY | 2020年 / 12卷 / 11期
关键词：
checkpoint inhibitors; clinical trials; developed countries; immunotherapy; latent tuberculosis; lung cancer; Mycobacterium tuberculosis; reactivation; screening; tuberculosis; REACTIVATION;
D O I：
10.2217/imt-2020-0069
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：759 / 762
页数：4
相关论文
共 50 条
  • [1] Incidence of Active Tuberculosis in Lung Cancer Patients Receiving Immune Checkpoint Inhibitors
    Fujita, Kohei
    Yamamoto, Yuki
    Kanai, Osamu
    Okamura, Misato
    Hashimoto, Masayuki
    Nakatani, Koichi
    Sawai, Satoru
    Mio, Tadashi
    OPEN FORUM INFECTIOUS DISEASES, 2020, 7 (05):
  • [2] Incidence of Active Tuberculosis in Lung Cancer Patients Receiving Immune Checkpoint Inhibitors
    Fujita, K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [3] Testing for latent tuberculosis before starting patients on immune checkpoint inhibitors
    Dhar, Chirag
    INDIAN JOURNAL OF CANCER, 2021, 58 (03) : 469 - 470
  • [4] Active and Latent Tuberculosis Infection in Patients Taking Immune Checkpoint Inhibitors
    Stroh, G.
    Peikert, T.
    Escalante, P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [5] Prevalence of Latent Tuberculosis in Lung Cancer Patients Receiving Immune Checkpoint Inhibitors: A South-East London Cohort Study
    Paine, Gabriel Wisenfeld
    Cox, Rosie
    Evans, Rosa
    Hudson, Jake
    Baker, Lucy
    Simpson, Thomas
    LUNG CANCER, 2025, 200
  • [6] Cardiotoxicity of Immune Checkpoint Inhibitors in Patients with Lung Cancer
    Chitturi, Kalyan R.
    Araujo-Gutierrez, Raquel
    McLean, Edward T.
    Xu, Jiaqiong
    Bhimaraj, Arvind
    Guha, Ashrith
    Hussain, Imad
    Trachtenberg, Barry H.
    JOURNAL OF CARDIAC FAILURE, 2019, 25 (08) : S50 - S50
  • [7] Development of tuberculosis in cancer patients receiving immune checkpoint inhibitors
    Im, Yunjoo
    Lee, Jeeyun
    Kim, Seok Jin
    Koh, Won-Jung
    Jhun, Byung Woo
    Lee, Se-Hoon
    RESPIRATORY MEDICINE, 2020, 161
  • [8] Immune checkpoint inhibitors in lung cancer
    Koleczko, S.
    Wolf, J.
    INTERNIST, 2020, 61 (07): : 676 - 681
  • [9] Active and latent tuberculosis infections in patients treated with immune checkpoint inhibitors in a non-endemic tuberculosis area
    Stroh, Gregory R.
    Peikert, Tobias
    Escalante, Patricio
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (11) : 3105 - 3111
  • [10] Active and latent tuberculosis infections in patients treated with immune checkpoint inhibitors in a non-endemic tuberculosis area
    Gregory R. Stroh
    Tobias Peikert
    Patricio Escalante
    Cancer Immunology, Immunotherapy, 2021, 70 : 3105 - 3111
12345